Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: The Women's Health Initiative Observational Study

Cancer

Volumn 106, Issue 3, 2006, Pages 654-663

  Rosenberg, Carol A ^a,b   Khandekar, Janardan ^a,b   Greenland, Philip ^b   Rodabough, Rebecca J ^c   McTiernan, Anne ^c  

^a Evanston Northwestern Healthcare ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Female; Melanoma; Neoplasm second primary; Post menopause; Risk; Skin neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MEDICAL RECORD; MELANOMA; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SECOND CANCER; SKIN CARCINOMA;

AGED; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 31544445286     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21627     Document Type: Article

References (58)

1. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol. 1995;141:916-922.
2. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med. 1996; 125:815-821.
3. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous melanoma. Screening implications. Cancer. 1995;75:707-714.
4. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer. 1999;80:511-515.
5. Levi F, La Vecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147:722-726.
6. Levi F, Randimbison L, La Vecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol. 1997;146:734-739.
7. Lindelof B, Sigurgeirsson B, Wallberg P, Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol. 1991;25:245-248.
8. Milan T, Pukkala E, Verkasalo PK, et al. Subsequent primary cancers after basal cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer. 2000;87:283-288.
9. Friedman GD, Tekawa IS. Association of basal cell skin cancer with other cancers (United States). Cancer Causes Control. 2000;11:891-897.
10. Efird JT, Friedman GD, Habel L, Tekawa IS, Nelson LM. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002;12:469-475.
11. Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA. 1998;280:910-912.
12. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344:975-983.
13. Strom SS, Yamamura Y. Epidemiology of nonmelanoma skin cancer. Clin Plast Surg. 1997;24:627-636.
14. Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM. Association of nonmelanoma skin cancer with second malignancy. The Women's Health Initiative Observational Study. Cancer. 2004;100:130-138.
15. Schottenfeld D. Basal-cell carcinoma of the skin: a harbinger of cutaneous and noncutaneous multiple primary cancer [editorial]. Ann Intern Med. 1996;125:852-854.
16. [no authors listed]. Design of Women's Health Initiative clinical trial and observation. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19:61-109.
17. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003;13:S107-S121.
18. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative Study Design. Ann Epidemiol. 2003;13:S5-S17.
19. McTiernan A, Kooperberg C, White E, et al. Recreational activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA. 2003;290:1331-1378.
20. Scotto J, Fears TR, Kraemer KH, Fraumeni JF. Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996:1313-1330.
21. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003;13:S122-S128.
22. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. 1992;327:2:1649-1662.
23. Rosso S, Zanetti R, Pippione M, Sancho-Garnier H. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res. 1998;8: 573-583.
24. Dubin N, Pasternak BS, Moseson M. Simultaneous assessment of risk factors for malignant melanoma and nonmelanoma skin lesions, with emphasis on sun exposure and related variables. Int J Epidemiol. 1990;19:811-819.
25. Balch CM, Soong S, Thompson JI. The natural history of melanoma and factors predicting outcome. In: Thompson JF, Morton DL, Kroon BB, editors. Textbook of melanoma. New York: Martin Dunitz, 2004:181-198.
26. Ming ME, Levy RM, Hoffstad OH, Filip J, Gimotty P, Margolis DJ. Validity of patient self-reported history of skin cancer. Arch Dermatol. 2004;140:730-735.
27. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
28. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341-1348.
29. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351:998-1012.
30. Gloster HM Jr., Brodland DG. The epidemiology of skin cancer. Dermatol Surg. 1996;22:217-226.
31. Scotto J, Fraumeni JF. Solar irradiation. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996:355-372.
32. Lang PG, Maize JC. Basal cell carcinoma. In: Rigel DS, Friedman RJ, Dzubow LM, Reintgen DS, Bystryn JC, Marks R, editors. Cancer of the skin. Philadelphia: Elsevier Saunders, 2005:101-132.
33. Armstrong B. Epidemiology of cutaneous melanoma and current trends. In: Thompson JF, Morton DL, Kroon BB, editors. Textbook of melanoma. New York: Martin Dunitz, 2004:65-80.
34. Palmer JS, Duffy DL, Box NF, et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotypes? Am J Genet. 2000;66:176-186.
35. Rivers JK. Is there more than one road to melanoma? Lancet. 2004;363:728-730.
36. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95:1878-1890.
37. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol. 1997; 133:1263-1270.
38. Clerici M, Shearer GM, Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm [review]. J Natl Cancer Inst 1998;90:261-263.
39. Kripke ML. Effects of UV radiation on tumor immunity. J Natl Cancer Inst. 1990;82:1392-1396.
40. Kripke ML. Ultraviolet radiation and immunobiology: something new under the sun. Cancer Res. 1994;54:6102-6105.
41. Morison WL. Effects of ultraviolet radiation on the immune system in humans. Photochem Photobiol. 1989;50:515-524.
42. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair and aging in basal cell carcinoma. A molecular epidemiology study. Proc Natl Acad Sci U S A. 1993;90: 1614-1618.
43. Wei Q, Lee JE, Gershenwald JE, et al. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003;95:308-315.
44. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991;88:10124-10128.
45. Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 1999;285:898-900.
46. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hot spots to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993;90:4216-4220.
47. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-776.
48. Rizos H, Becker TM, Holland EA. Cell cycle regulation in the melanocyte. In: Thompson JF, Morton DL, Kroon BB, editors. Textbook of melanoma. New York: Martin Dunitz, 2004:18-24.
49. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarker Prev. 2004;13:1271-1275.
50. Merlino G. The weakest link? Nature. 2005;436:33-35.
51. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999;91:1310-1316.
52. Carlson JA, Slominski A, Linette GP, Mihm MC, Ross JS. Biomarkers in melanoma: predisposition, screening and diagnosis [review]. Expert Rev Mol Diagn. 2003;3:163-184.
53. Geller AC, Annas GD. Epidemiology of melanoma and nonmelanoma skin cancer. Semin Oncol Nursing. 2003;19:2-11.
54. American Cancer Society. Cancer Facts and Figures 2004. Atlanta: American Cancer Society, 2004. Available at URL: http://www.cancer.org/downloads/STT/ CAFF_finalPWSecured.pdf [accessed July 1, 2004].
55. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
56. Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol. 1990;23:308-310.
57. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene. 2003;22:3042-3052.
58. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma. JAMA. 2004;292:2771-2776.